Bryan Mastis results 1
· Newest (Page 1/1, per page 25)
Author: Bryan Mastis ×Clear All Filters
Search Results
Pharmacokinetic/Pharmacodynamic Modeling of a Cell-Penetrating Peptide Phosphorodiamidate Morpholino Oligomer in mdx MiceNARA Subscribed
Purpose Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) have shown promise in treating Duchenne muscular dystrophy (DMD). We evaluated a semi-mechanistic pharmacokinetic (PK) and pharmacodynamic (PD) model to capture the relationship between plasma and muscle tissue exposure/response in mdx mice treated by mouse surrogate PPMO. Methods A single or repeated (every 4 weeks for 20 weeks) intravenous PPMO dose w...
Previous1Next